ArticleEndocrine connections2026
Learning curve of blood pressure management during phaeochromocytoma surgery without preoperative alpha-blockade dose escalation.
Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdrenalectomy without preoperative dose escalation of α-blockade is gaining popularity for managing phaeochromocytoma, showing comparable outcomes but shorter hospital stays and less postoperative hypotension. However, recent data showed an initial significant increase in intraoperative hypotension after transitioning to this approach, suggesting a learning curve. We evaluated this learning curve for the safe use of our α-blockade non-escalation workflow employing a risk-adjusted CUSUM (RA-CUSUM) analysis.
methodThis single-centre cohort study included phaeochromocytoma resections without preoperative α-blockade dose escalation from 2019 until 2023. All procedures were performed by an experienced operating theatre team, including anaesthesiologists and surgeons dedicated to phaeochromocytoma treatment. Intraoperative hypotension (time-weighted average (TWA) of mean arterial pressure (MAP) < 60 mmHg) was identified as primary learning curve outcome. RA-CUSUM analysis consisted of predicting intraoperative hypotension using a multivariable linear regression model corrected for established risk factors and modelling the relationship between the number of procedures and the cumulative difference in predicted and observed outcomes.
resultsA total of 44 procedures were evaluated employing the new preoperative α-blockade non-escalation strategy. RA-CUSUM analysis showed that the learning curve was completed after 19 surgeries. The median TWA of MAP < 60 mmHg was 2.29 (IQR: 0.45-4.16) mmHg. No perioperative complications related to haemodynamic instability occurred in the cohort. Time in the operating theatre and length of hospital stay remained consistent over time.
conclusionOur results confirm that transitioning to phaeochromocytoma resection without α-blockade dose escalation follows a learning curve. To ensure safe implementation, centres adopting the non-escalation workflow should meet certain conditions, with structured guidance or proctoring as possible measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.